COMMUNIQUÉS West-GlobeNewswire

CohBar Provides Update on CB4211 Clinical Trial

05/11/2018 - 15:00

CB4211 Phase 1 Clinical Trial Temporarily Suspended to Address Injection Site Reactions Will Host Conference Call on November 6, 2018 at 11:00 a.m. Eastern Time MENLO PARK, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- [...]

Correction: Release date of nine-month interim report (Q3) 2018 and audio cast

05/11/2018 - 14:59

Correction: The UK dial-in number was incorrect. Please find correct number below. On Friday, 9 November 2018, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its interim report for the six months ended 30 [...]

Golden Leaf Holdings Launches Golden Fruit Chews in Nevada

05/11/2018 - 14:45

PORTLAND. Ore., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]

RAMSAY GENERALE DE SANTE : Mise à disposition du Document de Référence 2018

05/11/2018 - 14:36

Mise à disposition du document de référence au 30 juin 2018 Ramsay Générale de Santé annonce le dépôt de son document de référence au 30 juin 2018 auprès de l'Autorité des Marchés Financiers (AMF) le 31 octobre 2018 [...]

Tyme Provides Clinical and Corporate Update for Fiscal 2Q 2019

05/11/2018 - 14:33

SM-88 to be included in pivotal Precision Promise pancreatic cancer trial led by Pancreatic Cancer Action Network (PanCAN) expected to commence in the first half of 2019 Interim data for SM-88 from Phase II pancreatic [...]

Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition

05/11/2018 - 14:30

Oral presentation on Saturday will feature efficacy and safety data from Expanded Phase 2 trial of rigosertib in combination with Azacitidine Three Poster presentations to feature pharmacokinetics, dose optimization, [...]

Milestone Scientific Receives Notice of Allowance for New U.S. Patent

05/11/2018 - 14:30

LIVINGSTON, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE: MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has [...]

Terra Tech Corp. and Golden Leaf Holdings Ltd. Sign Non-Binding Letter of Intent to Merge

05/11/2018 - 14:30

Combined Company to Control 41 Permits Across Cultivation, Manufacturing, Distribution and Retail Spanning Oregon, California and Nevada, in Addition to 21 Pending Permit Applications in Multiple Jurisdictions [...]

ARCA Biopharma announces phase 2B GENETIC-AF atrial fibrillation burden (AFB) results selected for presentation at american heart association 2018 scientific sessions

05/11/2018 - 14:30

Approximately 25% risk reduction for recurrence of AF seen in favor of Gencaro over active comparator as measured by AFB WESTMINSTER, Colo., Nov. 05, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a [...]

CLS Holdings USA Loans $5 Million to In Good Health, Continuing on its Path to Enter the Rapidly Expanding Massachusetts Market

05/11/2018 - 14:30

LAS VEGAS, Nov. 05, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]

Letter to Shareholders from Curt Fairbrother CEO, MedTainer Inc.

05/11/2018 - 14:30

CORONA, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Dear Shareholders: Tomorrow’s elections signify another milestone in the final run-up to the United States government changing, for all time, the current Schedule 1 [...]

NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs

05/11/2018 - 14:30

ST. LOUIS PARK, Minn., Nov. 05, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve [...]

International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial

05/11/2018 - 14:30

CARLSBAD, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

High Hampton Signs LOI to Acquire California Extracts Manufacturer -- CFN Media

05/11/2018 - 14:30

SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Rothman Orthopaedic Institute implements Allscripts® Practice Management (PM) to strengthen financial coordination and operational efficiency

05/11/2018 - 14:01

Allscripts PM solution goes live at one of the world’s leading orthopedic institutes CHICAGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) partnered with Rothman Orthopaedic Institute to deliver Allscripts [...]

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

05/11/2018 - 14:00

PLYMOUTH MEETING, Pa., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that the Company will participate in the following upcoming investment conferences: Stifel 2018 [...]

MyoKardia to Present Clinical Evidence of Mavacamten’s Effect on Diastolic Function at 2018 American Heart Association Scientific Sessions

05/11/2018 - 14:00

Diastolic Relaxation Typically Impaired in HCM Patients; Data Indicate Mavacamten May Improve Ability of the Left Ventricle to Relax and Fill Additional Clinical Evidence of Mavacamten’s Effect on Diastolic Function [...]

Data Collected by Exalenz Bioscience in Galectin Therapeutics’ Phase 2 NASH-CX Trial of GR-MD-02 to Be Presented at AASLD Annual Meeting

05/11/2018 - 14:00

NORCROSS, Ga., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that an abstract based on results obtained [...]

Spero Therapeutics Announces Positive Results from SPR720 IND-Enabling Studies and Plans to Initiate a Phase 1 Trial

05/11/2018 - 14:00

CAMBRIDGE, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]